Delivery Order SPE2DE24DA017-SPE2D626F668F
- Not listed
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $8,250.00 for the Arthrex ACP Double Syringe System on September 15, 2025. This fixed-price delivery order with economic price adjustment is scheduled for ultimate completion on September 18, 2025, and will be performed at the company's Naples, FL facility. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $10,393.29 for the Arthrex ACP Double Syringe System on December 10, 2025, with an ultimate completion date of December 15, 2025. This fixed-price delivery order with economic price adjustment falls under a larger single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471 million...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $2,475.00 for the Arthrex ACP Double Syringe System on November 25, 2025, with a completion date of December 1, 2025. This fixed-price delivery order with economic price adjustment was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., headquartered in Naples, Florida, was awarded a delivery order valued at $1,650 on November 7, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment has an ultimate completion date of November 13, 2025, and will be performed at the contractor's Naples, Florida location. The award was made without a set-aside designation, reflecting Arthrex's strong competitive position in federal procurement. The contract is funded through...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,665.20 for the Arthrex ACP Double Syringe System on April 24, 2025. This fixed-price contract with economic price adjustment carries an ultimate completion date of April 29, 2025, and will be performed in Naples, Florida. The award was issued by the Defense Logistics Agency's Medical Supply Chain to support the government's orthopedic medical device needs,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475 on August 6, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 11, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The contract carries no...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $51,760.94 for the Arthrex ACP Double Syringe System on November 18, 2025, with an ultimate completion date of November 21, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for providing medical...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has been awarded a delivery order valued at $9,900 for the Arthrex ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment was issued on September 3, 2025, with an ultimate completion date of September 17, 2025. The award represents a non-set-aside competitive procurement and will be...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F668FDelivery Order
Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical devices based in Naples, Florida, was awarded a delivery order valued at $2,475.00 for the Arthrex ACP Double Syringe System, with an ultimate completion date of December 5, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation and will be performed in Naples, Florida. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which procures orthopedic surgical products and biologics for Department of Defense and Department of Veterans Affairs healthcare facilities. This delivery order is issued under Arthrex's existing Indefinite Delivery Contract SPE2DE24D0020 with the Defense Logistics Agency's Medical Supply Chain, a comprehensive master contract valued at approximately $471 million and effective through September 1, 2029. The parent IDC authorizes the procurement of Arthrex's full portfolio of orthopedic surgical solutions, including implants, arthroscopic instruments, joint replacement technologies, and specialized biologics for military personnel and veterans across multiple surgical specialties. Arthrex serves as the prime contractor on this award with no identified subcontractors, demonstrating its established capability to directly fulfill federal orthopedic procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/1/25 |